Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsSurfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot StudyAcute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.Cytokine inhibition in the treatment of COPD.Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPDConcomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and miceChronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatA Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controlsDistinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.Validation of a multiprotein plasma classifier to identify benign lung nodulesAnti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPDMetabolic syndrome and chronic obstructive pulmonary disease.Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.Pulmonary biomarkers in COPD exacerbations: a systematic review.Biomarker discovery in asthma and COPD by proteomic approaches.Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.Development of a functional point-of-need diagnostic for myeloperoxidase detection to identify neutrophilic bronchitis.A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.Differences in systemic inflammation between cigarette and biomass smoke-induced COPDAsthma-COPD overlap is not a homogeneous disorder: further supporting data.Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C).Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD.Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.Lack of association between increased mitochondrial DNA4977 deletion and ATP levels of sputum cells from chronic obstructive pulmonary disease patients versus healthy smokers.
P2860
Q26766294-8DEDA6CC-A4DC-4C87-82B6-F1EEBACFC305Q28396135-68622186-2451-4E08-9303-96E29C505C11Q30371420-FEFA4721-FB4E-4CA4-BD2B-6D86D8E88E1AQ33568552-AB220EEB-1788-4005-A242-626D2FEA961DQ33612752-9354FED0-FFFB-482E-8C2B-5DE5F810BE52Q33844617-69FF0D7D-7920-4A39-9229-EB153BCA31B3Q33894887-8EF4A19C-A9EB-46AA-8ECD-706C3CC8FF12Q34228984-22860365-F379-4EBF-8A05-2D5857D09597Q34558199-E4DAC34E-13A0-4656-B3B0-04A72A6AAE94Q35042664-D68D6503-AAD4-4AC8-8961-382D087C4200Q35185482-23098F72-9BF5-4B0D-A27D-64F2F71CA594Q35241794-033E8C29-8F4B-4DCD-8D25-6E1228AAF541Q35531955-A3517B67-62A6-46C6-9A0F-C55F33593E6BQ35892456-FD74D975-CC00-4F5B-A44C-6B798F2834ECQ37102124-36EEDC2E-6B41-4BFD-8E53-C20FA879A453Q37156936-7E3D0006-C536-4B70-B014-DB36AD5B9A97Q38154291-D9B2FF20-ADCA-48B2-9EA3-0E29D1CEE559Q38245908-89843AA9-D705-47A1-AA57-B913C35F7D86Q38649641-853E436A-7EDE-4530-B8A9-4382482418A6Q40494951-2BA582D5-981C-43A7-82A9-2CA4E1FFD6F8Q41336850-3EB30C3F-3560-47F3-868B-16DB3CFCA339Q42032438-1E824AB1-CF05-4A4D-8BC0-371E2FFA67BAQ47149724-A9A86ADA-1B61-42FF-9733-11923CE1CEF8Q50934926-F8B3CECA-6C8B-46BC-9CCE-7B08B2862CE5Q51442234-BF5C7BE3-AF1C-4CA7-A12E-DFFB5429F4F1Q52684260-4863BD5B-24CC-49EE-A073-A9E0C92D0A94Q53232748-24CE1CCB-2A70-424A-A1C5-FBBAA71615F1
P2860
Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Repeatability of and relations ...... ies, serum, and induced sputum
@ast
Repeatability of and relations ...... ies, serum, and induced sputum
@en
Repeatability of and relations ...... ies, serum, and induced sputum
@nl
type
label
Repeatability of and relations ...... ies, serum, and induced sputum
@ast
Repeatability of and relations ...... ies, serum, and induced sputum
@en
Repeatability of and relations ...... ies, serum, and induced sputum
@nl
prefLabel
Repeatability of and relations ...... ies, serum, and induced sputum
@ast
Repeatability of and relations ...... ies, serum, and induced sputum
@en
Repeatability of and relations ...... ies, serum, and induced sputum
@nl
P2093
P2860
P921
P3181
P1433
P1476
Repeatability of and relations ...... ies, serum, and induced sputum
@en
P2093
Gereon Lauer
Gezim Lahu
Martin Elmlinger
Meike Müller
Norbert Krug
Peter Ernst
Stefan Röpcke
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0046207
P407
P577
2012-01-01T00:00:00Z